Stephen Liu: Biomarker results and the timing for lung cancer treatment

Stephen Liu shared on X:

“It’s critical to wait for biomarker results before starting treatment for lung cancer – how do we balance that with the urgency to start treatment quickly?

Advice from patient advocate Aurora Lucas and Drs. Mark Kris and Ilit Turgeman in this IASLC podcast.”

Source: Stephen Liu/X

Stephen Liu is an Associate Professor of Medicine at Georgetown University, where he holds the positions of Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center. As a board-certified medical oncologist specializing in lung cancer and drug development, Dr. Liu is known for his expertise in advanced thoracic malignancies.

His research focuses on novel therapeutic agents and innovative combinations to improve treatment outcomes for patients with lung cancer. Dr. Liu has received multiple teaching awards and actively engages in post-graduate education initiatives. Furthermore, he co-hosts the official podcast of the International Association for the Study of Lung Cancer (IASLC), “Lung Cancer Considered”.